Isotretinoin is not associated with inflammatory bowel disease even when compared with topical antibiotics and topical retinoids

Khalaf Kridin; Ralf J Ludwig

doi:10.1016/j.jaad.2023.11.004

Isotretinoin is not associated with inflammatory bowel disease even when compared with topical antibiotics and topical retinoids

J Am Acad Dermatol. 2024 Apr;90(4):e137-e138. doi: 10.1016/j.jaad.2023.11.004. Epub 2023 Nov 10.

Authors

Khalaf Kridin¹, Ralf J Ludwig²

Affiliations

¹ Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany; Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel; Unit of Dermatology and Skin Research Laboratory, Galilee Medical Center, Nahariya, Israel. Electronic address: dr_kridin@hotmail.com.
² Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany; Department of Dermatology, University of Lübeck, Lübeck, Germany.

PMID: 37951246
DOI: 10.1016/j.jaad.2023.11.004

No abstract available

Keywords: Crohn’s disease; acne; benzoyl peroxide; inflammatory bowel disease; irritable bowel syndrome; isotretinoin; tretinoin; ulcerative colitis.

Publication types

Letter

MeSH terms

Acne Vulgaris* / drug therapy
Administration, Topical
Anti-Bacterial Agents / adverse effects
Benzoyl Peroxide / therapeutic use
Humans
Inflammatory Bowel Diseases* / drug therapy
Isotretinoin / adverse effects
Retinoids / adverse effects
Tretinoin / therapeutic use

Substances

Isotretinoin
Retinoids
Anti-Bacterial Agents
Tretinoin
Benzoyl Peroxide